MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmed.2026.1728478

Медицинская библиотека · Frontiers in medicine · 2026

Therapeutic efficacy and safety of injectable platelet-rich plasma in women with stress urinary incontinence: a systematic review and meta-analysis.

Utama Bobby Indra, Birru Arif Bima Al, Cuandra Kevin Nathaniel, Puspita Ratna, Arianto Steven, Pranowo Galih Yudo, Saifana Qanita, Gandhy Made Aditya Krisnanta, Puteri Karisya Juwita, Mifindra Rafhy, Husodho Gabriela Valencia Putri, Alexander Rio Fernando, Yuliani Meda, NurCita Boenga, Tristan Christopher Daniel

СтатьяСистематический обзорПеревод в очереди

Аннотация

BACKGROUND

Stress urinary incontinence (SUI) is a prevalent pelvic floor disorder with significant effects on women's quality of life. While surgical and non-surgical interventions exist, limitations underscore the need for alternative therapies. Injectable platelet-rich plasma (PRP) has emerged as a regenerative approach targeting tissue restoration. This study aimed to systematically evaluate the efficacy and safety of PRP injections for female SUI.

METHODS

This systematic review and meta-analysis adhered to the PRISMA guidelines. Comprehensive searches of PubMed, Scopus, and Cochrane Library up to April 2025 identified randomized controlled trials (RCTs) and quasi-experimental studies assessing PRP for SUI. The review protocol was prospectively registered in the International Prospective Register of Systematic Reviews (CRD420251118485). Eligible studies reported outcomes on symptom severity, urodynamic parameters, quality of life, or adverse events. Risk of bias was assessed using Cochrane RoB 2.0 for RCTs and the NHLBI tool for before-and-after studies. Pooled effect sizes were calculated using random- or fixed-effects models as appropriate.

RESULTS

Eight studies (three RCTs and five quasi-experimental; n = 257) were included. PRP significantly improved symptom severity, with pooled reductions in UDI-6 and ICIQ-SF scores at 1-3 months. Urodynamic analysis revealed significant increases in abdominal leak point pressure (MD = 51.07; 95% CI: 36.21-65.93; p < 0.0001), while functional profile length remained unchanged. Quality-of-life scores (IIQ-7, ICIQ-SF) showed consistent improvement. Reported adverse events were mild and self-limiting, with no serious complications observed.

CONCLUSION

Injectable PRP demonstrates promising short-term efficacy in reducing symptoms, improving urodynamic function, and enhancing quality of life in women with SUI, with a favorable safety profile. Larger, standardized RCTs with longer follow-up are needed to validate durability and define its role relative to established therapies.

SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251118485, CRD420251118485.

Для цитирования: Utama Bobby Indra, Birru Arif Bima Al, Cuandra Kevin Nathaniel, Puspita Ratna, Arianto Steven, Pranowo Galih Yudo, Saifana Qanita, Gandhy Made Aditya Krisnanta, Puteri Karisya Juwita, Mifindra Rafhy, Husodho Gabriela Valencia Putri, Alexander Rio Fernando, Yuliani Meda, NurCita Boenga, Tristan Christopher Daniel. Therapeutic efficacy and safety of injectable platelet-rich plasma in women with stress urinary incontinence: a systematic review and meta-analysis.. Frontiers in medicine. 2026. DOI: 10.3389/fmed.2026.1728478.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.